Guidelines for the Diagnosis and Treatment of Adult Familial Hypercholesterolemia 2022
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Guidelines for the Diagnosis and Treatment of Adult Familial Hypercholesterolemia 2022
Authors
Keywords
-
Journal
Journal of Atherosclerosis and Thrombosis
Volume -, Issue -, Pages -
Publisher
Japan Atherosclerosis Society
Online
2023-01-21
DOI
10.5551/jat.cr005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Patients With LDLR and PCSK9 Gene Variants Experienced Higher Incidence of Cardiovascular Outcomes in Heterozygous Familial Hypercholesterolemia
- (2021) Takahito Doi et al. Journal of the American Heart Association
- Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments
- (2021) Shingo Koyama et al. Journal of Atherosclerosis and Thrombosis
- Diagnosis and Management of Sitosterolemia 2021
- (2021) Hayato Tada et al. Journal of Atherosclerosis and Thrombosis
- Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study
- (2021) Shizuya Yamashita et al. Journal of Atherosclerosis and Thrombosis
- Factors Associated with Carotid Atherosclerosis and Achilles Tendon Thickness in Japanese Patients with Familial Hypercholesterolemia: A Subanalysis of the Familial Hypercholesterolemia Expert Forum (FAME) Study
- (2021) Masatsune Ogura et al. Journal of Atherosclerosis and Thrombosis
- Achilles Tendon Thickness Assessed by X-ray Predicting a Pathogenic Mutation in Familial Hypercholesterolemia Gene
- (2021) Hayato Tada et al. Journal of Atherosclerosis and Thrombosis
- Long-Term Evolocumab in Patients With Familial Hypercholesterolemia
- (2020) Raul D. Santos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease
- (2020) Pengwei Hu et al. CIRCULATION
- The first Japanese cases of familial hypercholesterolemia due to a known pathogenic APOB gene variant, c.10580G>A: p.(Arg3527Gln)
- (2020) Mika Hori et al. Journal of Clinical Lipidology
- A catalog of the pathogenic mutations of LDL receptor gene in Japanese familial hypercholesterolemia
- (2020) Hayato Tada et al. Journal of Clinical Lipidology
- Worldwide Prevalence of Familial Hypercholesterolemia
- (2020) Sabina O. Beheshti et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Risk of Ischemic Stroke and Peripheral Arterial Disease in Heterozygous Familial Hypercholesterolemia: A Meta-Analysis
- (2019) Leo E. Akioyamen et al. ANGIOLOGY
- Familial Hypercholesterolemia and Lipoprotein Apheresis
- (2019) Hisashi Makino et al. Journal of Atherosclerosis and Thrombosis
- 20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia
- (2019) Ilse K. Luirink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dietary Intake during 56 Weeks of a Low-Fat Diet for Lomitapide Treatment in Japanese Patients with Homozygous Familial Hypercholesterolemia
- (2018) Noriko Kameyama et al. Journal of Atherosclerosis and Thrombosis
- Sitosterolemia, Hypercholesterolemia, and Coronary Artery Disease
- (2018) Hayato Tada et al. Journal of Atherosclerosis and Thrombosis
- Assessment of arterial stiffness in patients with familial hypercholesterolemia
- (2018) Hayato Tada et al. Journal of Clinical Lipidology
- Autosomal Recessive Hypercholesterolemia
- (2018) Laura D’Erasmo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Long-term safety and efficacy of alirocumab in patients with heterozygous familial hypercholesterolemia: An open-label extension of the ODYSSEY program
- (2018) Michel Farnier et al. ATHEROSCLEROSIS
- Oligogenic familial hypercholesterolemia, LDL cholesterol, and coronary artery disease
- (2018) Hayato Tada et al. Journal of Clinical Lipidology
- Efficacy and safety of lipoprotein apheresis in children with homozygous familial hypercholesterolemia: A systematic review
- (2018) Ilse K. Luirink et al. Journal of Clinical Lipidology
- Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia
- (2017) Hayato Tada et al. EUROPEAN HEART JOURNAL
- Open-label therapy with alirocumab in patients with heterozygous familial hypercholesterolemia: Results from three years of treatment
- (2017) Robert Dufour et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Efficacy and Safety of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia
- (2017) Mariko Harada-Shiba et al. Journal of Atherosclerosis and Thrombosis
- Half a Century Tales of Familial Hypercholesterolemia (FH) in Japan
- (2017) Hiroshi Mabuchi Journal of Atherosclerosis and Thrombosis
- Efficacy of Rosuvastatin in Children With Homozygous Familial Hypercholesterolemia and Association With Underlying Genetic Mutations
- (2017) Evan A. Stein et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis
- (2017) Leo E Akioyamen et al. BMJ Open
- Therapeutic efficacy and safety of PCSK9-monoclonal antibodies on familial hypercholesterolemia and statin-intolerant patients: A meta-analysis of 15 randomized controlled trials
- (2017) Li Jun Qian et al. Scientific Reports
- Lipoprotein apheresis is essential for managing pregnancies in patients with homozygous familial hypercholesterolemia: Seven case series and discussion
- (2016) Masatsune Ogura et al. ATHEROSCLEROSIS
- Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial
- (2016) Patrick M. Moriarty et al. EUROPEAN HEART JOURNAL
- Efficacy and Safety of Pitavastatin in Japanese Male Children with Familial Hypercholesterolemia
- (2016) Mariko Harada-Shiba et al. Journal of Atherosclerosis and Thrombosis
- Proprotein convertase subtilisin/kexin 9 V4I variant with LDLR mutations modifies the phenotype of familial hypercholesterolemia
- (2016) Naotaka Ohta et al. Journal of Clinical Lipidology
- Familial defective apolipoprotein B-100: A review
- (2016) Lars H. Andersen et al. Journal of Clinical Lipidology
- Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia
- (2016) Amit V. Khera et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Statins in Familial Hypercholesterolemia
- (2016) Joost Besseling et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Systematic Review of Low‐Density Lipoprotein Cholesterol Apheresis for the Treatment of Familial Hypercholesterolemia
- (2016) Anthony Wang et al. Journal of the American Heart Association
- Assessment of Coronary Atherosclerosis in Patients With Familial Hypercholesterolemia by Coronary Computed Tomography Angiography
- (2015) Hayato Tada et al. AMERICAN JOURNAL OF CARDIOLOGY
- Association Between Cholesterol Efflux Capacity and Atherosclerotic Cardiovascular Disease in Patients With Familial Hypercholesterolemia
- (2015) Masatsune Ogura et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia
- (2015) John J.P. Kastelein et al. EUROPEAN HEART JOURNAL
- The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis
- (2015) Michael J. Lipinski et al. EUROPEAN HEART JOURNAL
- Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
- (2015) Erik S. Stroes et al. EUROPEAN HEART JOURNAL
- Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia
- (2015) Dick C. Chan et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial
- (2015) Frederick J Raal et al. LANCET
- PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
- (2015) Frederick J Raal et al. LANCET
- Effect of the Proprotein Convertase Subtilisin/Kexin 9 Monoclonal Antibody, AMG 145, in Homozygous Familial Hypercholesterolemia
- (2013) Evan A. Stein et al. CIRCULATION
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
- (2013) B. G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study
- (2013) Philippa J Talmud et al. LANCET
- Efficacy and Safety of Coadministration of Rosuvastatin , Ezetimibe , and Colestimide in Heterozygous Familial Hypercholesterolemia
- (2011) Masa-aki Kawashiri et al. AMERICAN JOURNAL OF CARDIOLOGY
- Lipoprotein(a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemia
- (2011) Marit S. Nenseter et al. ATHEROSCLEROSIS
- Reduction in Mortality in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in Lipid-Lowering Therapy
- (2011) Frederick J. Raal et al. CIRCULATION
- Effects of Statin on Small Dense Low-Density Lipoprotein Cholesterol and Remnant-Like Particle Cholesterol in Heterozygous Familial Hypercholesterolemia
- (2011) Tsuyoshi Nozue et al. Journal of Atherosclerosis and Thrombosis
- Long-Term Probucol Treatment Prevents Secondary Cardiovascular Events: a Cohort Study of Patients with Heterozygous Familial Hypercholesterolemia in Japan
- (2011) Shizuya Yamashita et al. Journal of Atherosclerosis and Thrombosis
- Impact of Statin Treatment on the Clinical Fate of Heterozygous Familial Hypercholesterolemia
- (2011) Mariko Harada-Shiba et al. Journal of Atherosclerosis and Thrombosis
- Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan
- (2010) Hiroshi Mabuchi et al. ATHEROSCLEROSIS
- Complexity of molecular genetics of dyslipidemia in a family highly susceptible to ischemic heart disease
- (2010) H. K. Jensen et al. CLINICAL GENETICS
- Efficacy and Safety of Rosuvastatin Therapy for Children With Familial Hypercholesterolemia
- (2010) Hans J. Avis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The E32K variant of PCSK9 exacerbates the phenotype of familial hypercholesterolaemia by increasing PCSK9 function and concentration in the circulation
- (2009) Tohru Noguchi et al. ATHEROSCLEROSIS
- Management of fertility in women with familial hypercholesterolaemia: summary of NICE guidance
- (2009) M Thorogood et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Recommendations for the use of LDL apheresis
- (2008) G.R. Thompson ATHEROSCLEROSIS
- Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
- (2008) John J.P. Kastelein et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now